Keeping Generics Off the Market

Jazz Pharmaceuticals Anticompetitive Agreements on Xyrem Class Action

In recent years, we’ve seen a number of antitrust cases where a pharmaceutical company with a lucrative drug is accused of conspiring with generics companies to keep generic versions of that drug off the market. This class action alleges that Jazz Pharmaceuticals, related Jazz companies, and a long list of other drug companies conspired to  Read more

AstraZeneca Seroquel XR Generic Delay Antitrust Class Action

A number of antitrust class actions in recent years have centered on covert agreements between a company with a popular and lucrative drug and one or more other companies who may wish to put out a generic version. In this antitrust class action, the complaint claims that AstraZeneca companies entered into agreements with Handa Pharmaceuticals,  Read more

Bystolic Drug Companies Noncompete Agreements Antitrust Class Action

When it’s time for a “blockbuster” drug’s patent to expire, makers of generics are normally in a hurry to create their own versions. However, the complaint for this antitrust class action alleges that those involved with the drug Bystolic entered into noncompete agreements with potential competitors, to delay the entry of generics into the market.  Read more